Skip to content

Current ratio at other companies

Procter & Gamble logo
Procter & GamblePG
0.7×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
-0.2×
Perrigo Company logo
Perrigo CompanyPRGO
2.7×+0.4×
HRO
HarrowHROW
2.5×+1.6×
Opko Health logo
Opko HealthOPK
3.6×+1.1×
Bausch Health Companies logo
Bausch Health CompaniesBHC
1.3×0.0×

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.24B-45.6%
Enterprise value$3.22B-36.5%
P/E11.8×-7.4×
P/S2.1×-1.6×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×

Where this comes from

Calculated from Prestige Consumer Healthcare’s reported figures.

Based on the most recent quarter.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's current ratio?
Prestige Consumer Healthcare (PBH) reported current ratio of 3.6× in Q1 2026.
How has Prestige Consumer Healthcare's current ratio changed year-over-year?
Prestige Consumer Healthcare's current ratio decreased by 15.1% year-over-year, from 4.2× to 3.6×.
What is the long-term trend for Prestige Consumer Healthcare's current ratio?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's current ratio has grown at a 10.1% compound annual growth rate (CAGR), from 2.2× to 3.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.